Drug Type Small molecule drug |
Synonyms ART 26.12 |
Target |
Mechanism FABP5 inhibitors(Fatty acid binding protein 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Peripheral Nervous System Diseases | IND Approval | US | 15 Jul 2024 | |
Generalized anxiety disorder | Preclinical | GB | 01 Nov 2024 | |
Prostatic Cancer | Preclinical | GB | 01 Nov 2024 | |
Psoriasis | Preclinical | GB | 01 Nov 2024 | |
Breast Cancer | Preclinical | US | 01 Jul 2024 | |
Ostealgia | Preclinical | US | 01 Jul 2024 | |
Neoplasms | Preclinical | US | 11 Dec 2017 |